Rubius Therapeutics, Inc.

VANGUARD GROUP INC

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/10/2023

Shares

1,676,669

Value ($000)

293

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/10/2023	293	0.0%	1,676,669	12/31/2022
2022 Q3	11/14/2022	740	0.0%	1,705,288	9/30/2022
2022 Q2	8/12/2022	1,648	0.0%	1,937,193	6/30/2022
2022 Q1	5/13/2022	12,843	0.0%	2,330,725	3/31/2022
2021 Q4	2/14/2022	31,427	0.0%	3,246,641	12/31/2021
2021 Q3	11/12/2021	57,843	0.0%	3,235,007	9/30/2021
2021 Q2	8/13/2021	79,148	0.0%	3,242,403	6/30/2021
2021 Q1	5/14/2021	82,113	0.0%	3,098,602	3/31/2021
2020 Q4	2/12/2021	18,281	0.0%	2,408,755	12/31/2020
2020 Q3	11/16/2020	11,869	0.0%	2,369,274	9/30/2020
2020 Q2	8/14/2020	18,892	0.0%	3,159,130	6/30/2020
2020 Q1	5/15/2020	13,370	0.0%	3,004,433	3/31/2020
2019 Q4	2/14/2020	28,392	0.0%	2,988,657	12/31/2019